Skip to main content Accessibility help
×
Home

Differential illness intrusiveness associated with sleep-promoting medications

  • GM Devins (a1) (a2) (a3), M Flanigan (a3), JAE Fleming (a4), R Morehouse (a5), A Moscovitch (a6), J Plamondon (a7), L Reinish (a3) and CM Shapiro (a2)...

Summary

Differences in daytime sleepiness, lifestyle disruptions, and emotional distress were compared across nine groups taking sleep-promoting substances. Groups included individuals taking zopiclone (n = 274), amitriptyline (n = 107), lorazepam (n = 258), oxazepam (n= 141), diphenhydramine HCl (n = 99), triazolam(n = 137), long acting benzodiazepines (n = 120), temazepam (n = 176), and miscellaneous other medications (n = 286). Data were gathered by self-report, using standardized instruments in a mail-back questionnaire procedure. Respondents included the first 1,598 participants enrolled in a Canadian multicentre project, including six sites attached to academic psychiatric units. Results indicated that quality of life effects differed across groups in both daytime sleepiness and lifestyle disruptions (illness intrusiveness), but not in depressive symptoms. Daytime sleepiness was significantly higher among people taking diphenhydramine HCl as compared to temazepam, zopiclone, lorazepam, and oxazepam. Illness intrusiveness was significantly higher among patients taking amitriptyline as compared to those taking triazolam, oxazepam, long-acting benzodiazepines, and zopiclone. It may be useful to inform patients of differences in psychosocial outcomes when prescribing hypnotic medications.

Copyright

References

Hide All
Binik, YMDevins, GMOrme, CMPsychological stress and coping in end-stage renal disease. In: Neufeld, RWJ ed. Advances in the investigation of psychological stress New York: Wiley, 1989 305–42
Binik, YMChowanec, GDQuality of life. In: Garovoy, MRGuttmann, RD ed. Renal Transplantation New York: Churchill Livingstone, 1986 341–53
Binik, YMChowanec, GDDevins, GMMarital role strain, illness intrusiveness, and their impact on marital and individual adjustment in end-stage renal disease. Psychol Health 1990;4:245–57
Broughton, RJShapiro, CMParasomnias (vol 8 of 10).Sleep solutions St Laurent, Quebec: Komunicom Publications, 1992
Croog, SHLevine, STesta, MA, et al. The effects of antihyper-tensive therapy on the quality of life. N Engl J Med 1986;314:1657–64
Currie, DJChoosing the right hypnotic: pharmacotherapy of sleep disturbance. In: Kumar, VMMallick, HNNayar, U ed. Sleep-wakefulness New Delhi: Wiley Eastern, 1993 133–7
Derogatis, LRThe SCL-90-R administration, scoring, and procedures manual I Baltimore: Clinical Psychometric Research, 1977
Devins, GMEnhancing personal control and minimizing illness intrusiveness. In: Kutner, NGCardenas, DDBower, JD ed. Maximizing rehabilitation in chronic renal disease New York: PMA, 1989 109–36
Devins, GMIllness intrusiveness and the psychosocial impact of end-stage renal disease. In: Hardy, MAKiernan, JKutscher, AHCahill, LBevenitsky, AI ed. Psychosocial aspects of end-stage renal disease: issues of our times New York: Haworth Press, 1991 83102
Devins, GMPsychosocial impact of illness from a developmental-systems perspective: New directions for health psychology. Can J Behav Sci 1993;25:329–31
Devins, GMPsychosocial issues in end-stage renal disease. Adv Renal Repl Ther 1994;1:195–7
Devins, GMIllness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Adv Renal Repl Ther 1994;1:251–63
Devins, GMBinik, YMHutchinson, TAHollomby, DJBarre, PEGuttmann, RDThe emotional impact of end-stage renal disease: importance of patients'perceptions of intrusiveness and control. Int J Psychiat Med 1983;13:327–43
Devins, GMEdworthy, SMGuthrie, NGMartin, LIllness intrusiveness in rheumatoid arthritis: differential impact on depressive symptoms over the adult lifespan. J Rheumatol 1992;19:709–15
Devins, GMEdworthy, SMPaul, LC, et al. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psychosom Res 1993;37:163–70
Devins, GMEdworthy, SMSeland, TPKlein, GMPaul, LCMandin, HDifferences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis 1993;181:377–81
Devins, GMMandin, HHons, RB, et al. Illness intrusiveness and quality of life in end-stage renal disease: comparison and stabilitym across treatment modalities. Health Psychol 1990;9:117–42
Devins, GMOrme, CMCenter for epidemiologic studies depression scale. In: Keyser, DJSweetland, RC ed. Test Critiques 2nd ed. Kansas: Test Corporation of America, 1985 144–60
Devins, GMOrme, CMCostello, CG, et al. Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Health 1988;2:139–56
Devins, GMSeland, TPEmotional impact of multiple sclerosis: recent findings and suggestions for future research. Psychol Bull 1987;101:363–75
Devins, GMSeland, TPKlein, GMEdworthy, SMSaary, MJStability and determinants of psychosocial well being in multiple sclerosis. Rehabil Psychol 1993;38:1126
Devins, GMStam, HJKoopmans, JPPsychosocial impact of laryn-gectomy mediated by perceived stigma and illness intrusiveness. Can J Psychiat 1994;39:608–16
Evans, RWManninen, DLGarrison, LP, et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985;312:553–9
Flemming, JAEShapiro, CMSleep solutions.Insomnia management vol 2 of 10 St.-Laurent, Quebec: Komunicom Publications, 1992
Ford, DEKamerow, DBEpidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?. JAMA 1989;262:1479–84
Johns, MWA new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;4:540–5
Kales, AKales, JD ed. Evaluation and treatment of insomnia New York: Oxford University Press, 1984
Kasper, SWehr, TABartko, JJGaist, PARosenthal, NEEpidemiological findings of seasonal changes in mood and behavior: a telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry 1989;46:823–33
Najman, JMLevine, SEvaluating the impact of medical care and technologies on the quality of life: a review and critique. Soc Sci Med 1981;15:107–15
Radloff, LSThe CES-D scale: a self-report depression scale for research in the general population. App Psychol Meas 1977;3:385401
Rodin, GMVoshart, KDepressive symptoms and functional impairment in the medically ill. Gen Hosp Psychiatry 1987;9:251–8
Schuessler, KFFisher, GAQuality of life research and sociology. Ann Rev Social 1985;11:129–49
Shapiro, CMMacFarlane, JGHussain, MG ed. Conquering insomnia Hamilton: Ont. Empowering Press, 1994
Shapiro, CMSandor, PSleep patterns in depression and anxiety: theory and pharmacological effects. J Psychosom Res 1994; 38: 125–40
Troidl, HKusche, JVestweber, KEypasch, EKoeppen, LBouillon, BQuality of life: an important endpoint both in surgical practice and research. J Chron Dix 4061987 523–8

Keywords

Differential illness intrusiveness associated with sleep-promoting medications

  • GM Devins (a1) (a2) (a3), M Flanigan (a3), JAE Fleming (a4), R Morehouse (a5), A Moscovitch (a6), J Plamondon (a7), L Reinish (a3) and CM Shapiro (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Differential illness intrusiveness associated with sleep-promoting medications

  • GM Devins (a1) (a2) (a3), M Flanigan (a3), JAE Fleming (a4), R Morehouse (a5), A Moscovitch (a6), J Plamondon (a7), L Reinish (a3) and CM Shapiro (a2)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *